Pharmaceuticals, Biotechnology and Life Sciences
EDISON, N.J., Sept. 26, 2022 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial…
CAMBRIDGE, Mass., Sept. 26, 2022 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage cell therapy company with a…
Mupadolimab clinical trial in China will be conducted by Angel PharmaceuticalsBURLINGAME, Calif., Sept. 26, 2022 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals,…
AUSTIN, Texas, Sept. 26, 2022 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing a novel oral therapeutic candidate,…
– $238 Million in Upfront Payment Received at Closing with Additional $136.5 Million in Potential Milestone Payments Plus Royalties –…
Guerbet obtains one million euros of public funding from Bpifrance (France 2030 investment plan) for a project developing artificial intelligence…
Company announcementOrphazyme A/SNo. 36/2022 www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, September 26, 2022 – Orphazyme A/S (ORPHA.CO) (the “Company”)…
– Order for Approximately $10 Million Funded by the European Commission – – Orders for Approximately $6 Million Received…
Parallel processing using TCXpress™ and iTCXpress™ platforms significantly increases throughput, reduces the cost and shortens the timing of identifying novel…
CUMBERLAND, Md., Sept. 26, 2022 (GLOBE NEWSWIRE) — RS BioTherapeutics, whose mission is to harness its strong and thorough understanding…